Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MD.0000000000011053 http://scihub22266oqcxt.onion/10.1097/MD.0000000000011053 C6034564!6034564!29923995     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Medicine+(Baltimore) 2018 ; 97 (25): ä Nephropedia Template TP {{tp|p=29923995|t=2018. Adalimumab therapy in hepatitis B virus-negative polyarteritis nodosa: A case report |pdf=|usr=}}{{29923995}} gab.com Text Adalimumab therapy in hepatitis B virus-negative polyarteritis nodosa: A case report JO: Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=29923995 #FOAvip Introduction:: Polyarteritis nodosa (PAN) is a difficult-to-treat rheumatology disorder, and biologic agents have been used in such patients with a treatment failure or the disease relapse. Case presentation:: We report a 42-year-old male Han Chinese who received adalimumab (ADA) alone during his vasculitis relapse, manifesting with weight loss, ankle arthritis, testicular inflammation and new-onset hypertension. Under the ADA 40?mg biweekly subcutaneous injection, there were the disappearance of clinical activity and no disease flares with a follow-up period of 26 months. Conclusion:: The clinical observation in this patient suggests a potential efficacy of ADA therapy in controlling the disease activity of PAN. Twit Text FOAVip Adalimumab therapy in hepatitis B virus-negative polyarteritis nodosa: A case report ????Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=29923995 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29923995 #FOAvip English Wikipedia <ref>{{Cite pmid|29923995}}</ref> Adalimumab therapy in hepatitis B virus-negative polyarteritis nodosa: A case report #MMPMID29923995 Wang CR; Yang CC Medicine (Baltimore) 2018[Jun]; 97 (25): ä PMID29923995show ga Introduction:: Polyarteritis nodosa (PAN) is a difficult-to-treat rheumatology disorder, and biologic agents have been used in such patients with a treatment failure or the disease relapse. Case presentation:: We report a 42-year-old male Han Chinese who received adalimumab (ADA) alone during his vasculitis relapse, manifesting with weight loss, ankle arthritis, testicular inflammation and new-onset hypertension. Under the ADA 40?mg biweekly subcutaneous injection, there were the disappearance of clinical activity and no disease flares with a follow-up period of 26 months. Conclusion:: The clinical observation in this patient suggests a potential efficacy of ADA therapy in controlling the disease activity of PAN. äAdalimumab therapy in hepatitis B virus-negative polyarteritis nodosa:(epmc).pdf DeepDyve Pubget Overpricing